Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 1 art units • 1 examiners • 0 of 2 (0%) have an AI response strategy ready
Capsulated Systems Inc. currently manages 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. Despite having 2 actions, the company's prosecution is concentrated under 1 distinct examiner and 1 distinct art unit. This indicates that all current active matters are being reviewed within a specialized channel of the patent office, which leads to a uniform examination experience for the applicant's portfolio.
KASSA, TIGABU is the busiest examiner for the portfolio, overseeing 2 busiest examiner pending office actions. This examiner is responsible for the company's active workload. For the practitioner, this means that the prosecution of the active portfolio is subject to the examination style and requirements of 1 individual in 1 art unit. This centralization requires a strategy that addresses the specific technical interpretations of KASSA, TIGABU across the pending matters in the Biotechnology & Pharmaceuticals area.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KASSA, TIGABU | 2 | 36.7% | +27.9% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17152659 | METHODS FOR PROVIDING LONG-LASTING ANESTHETIC EFFECT USING MICROPARTICLES | KASSA, TIGABU | 59d overdue |
| 16549701 | Prolonged Release of Local Anesthetics Using Microparticles and Surgery Applications | KASSA, TIGABU | 59d overdue |
| Art Unit | Apps |
|---|---|
| 1619 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17152659 | METHODS FOR PROVIDING LONG-LASTING ANESTHETIC EFFECT USING MICROPARTICLES | KASSA, TIGABU | 1619 | §103 | Non-Final OA | 59d overdue | Pending | Jan 19, 2021 |
| 16549701 | Prolonged Release of Local Anesthetics Using Microparticles and Surgery Applications | KASSA, TIGABU | 1619 | §103 | Non-Final OA | 59d overdue | Pending | Aug 23, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial